Statera Biopharma Inc
(STAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 0 | 0 | 0 | 0 | 63 |
| Gross Profit | N/A | N/A | N/A | N/A | 63 |
| Operating Expenses | 6,324 | 5,194 | 3,075 | 6,171 | 655 |
| Operating Income | -6,324 | -5,194 | -3,295 | -6,171 | -592 |
| Interest Expense | 282 | 93 | 0 | 0 | 0 |
| Other Income | 0 | 0 | -2,142 | 492 | 216 |
| Pre-tax Income | -6,605 | -5,287 | -5,437 | -5,679 | -377 |
| Net Income Continuous | -6,605 | -5,287 | -5,437 | -5,679 | -377 |
| Minority Interests | N/A | N/A | N/A | N/A | -7 |
| Net Income | $-6,605 | $-5,287 | $-5,457 | $-5,679 | $-370 |
| EPS Basic Total Ops | -0.27 | -0.22 | 0.26 | -1.84 | -0.03 |
| EPS Basic Continuous Ops | -0.27 | -0.22 | 0.27 | -1.84 | -0.03 |
| EPS Diluted Total Ops | -0.27 | -0.22 | 0.26 | -1.84 | -0.03 |
| EPS Diluted Continuous Ops | -0.27 | -0.22 | 0.27 | -1.84 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -0.04 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-6,322 | $-5,193 | $-3,075 | $-6,171 | $-589 |